Transfected Stable Cell Lines

Human ERBB2 (V773M) NIH/3T3 Cell Line

  • For research use only

Cat No.

ABC-X0315C

Product Type

Overexpression Stable Cell Lines

Cell Type

Fibroblast

Species

Human

Host Cell

NIH/3T3

Source Organ

Embryo

Disease

Normal

Storage

Liquid Nitrogen

The ERBB2 (V773M) NIH/3T3 Cell Line supports investigation of HER2 mutations associated with oncogenic signaling and resistance to HER2-targeted therapies.

Product Image

Description

Human ERBB2 (V773M) NIH/3T3 Overexpression Cell Line is a genetically engineered model derived from NIH/3T3 mouse fibroblast cells based on customers’ requirement. The cell line stably expresses the human ERBB2 (V773M) mutant via lentiviral-mediated integration. Engineered cells are maintained under low passage conditions (<P20), and expression is validated at the gene level using qRT-PCR. Target ERBB2, also known as HER2, is a member of the EGFR family of receptor tyrosine kinases. The V773M mutation resides in the kinase domain and has been implicated in aberrant signaling in various cancers, including breast and gastric cancer. This alteration can enhance ligand-independent dimerization and downstream PI3K/AKT and MAPK pathway activation. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers' research needs.

Species

Human

Cat.No

ABC-X0315C

Product Category

Transfected Stable Cell Lines

Size/Quantity

1 vial

Cell Type

Fibroblast

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO2

Source Organ

Embryo

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

NIH/3T3

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • This cell line is a useful model for evaluating oncogenic signaling driven by ERBB2 (V773M) and assessing sensitivity to HER2-targeted agents, including small-molecule inhibitors and monoclonal antibodies. It enables mechanistic studies and drug discovery related to HER2-driven malignancies.

Inquiring Human ERBB2 (V773M) NIH/3T3 Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button